Ignite Creation Date:
2025-12-25 @ 4:06 AM
Ignite Modification Date:
2026-03-10 @ 11:28 PM
Study NCT ID:
NCT02764320
Status:
COMPLETED
Last Update Posted:
2021-11-12
First Post:
2016-05-04
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
The MOTS (Medication Overuse Treatment Strategy) Trial
Sponsor:
Mayo Clinic
Organization:
Study Overview
Official Title:
Determining the Optimal Treatment Strategy for Patients Who Have Chronic Migraine With Medication Overuse
Status:
COMPLETED
Status Verified Date:
2021-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
MOTS
Brief Summary:
There are two commonly used treatment strategies for treating patients who have chronic migraine with medication overuse. This study will compare the outcomes amongst patients randomized to one of the two treatment strategies.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
Secondary ID Infos
| Secondary ID | Type | Domain | Link | View |
|---|---|---|---|---|
| PCORI | OTHER_GRANT | PCS-1504-30133 | View |